Simulations Plus, Inc.

SLP

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
SLP
CIK0001023459
SIC7373
SectorManufacturing
Industry CategoryComputer Software
Industry GroupComputer Integrated Systems Design

Contact

Address800 PARK OFFICES DRIVE, SUITE 401, RESEARCH TRIANGLE PARK, NC, 27709
Website simulations-plus.com
Phone661-723-7723
CEOShawn M. OConnor
Employees160

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$80.38 million
Pre-Tax Income$-69.40 million
Net Income$-63.19 million
Net Income to Common$-63.19 million
EPS$-3.15
View All
Balance Sheet
Cash$26.95 million
Assets$134.36 million
Liabilities$10.58 million
Common Equity$123.78 million
Liabilities & Equity$134.36 million
View All
Cash Flow Statement
Calculations
NOPAT$-50.78 million
EBITDA$-60.44 million
Price to EarningsN/A
Price to Book$2.08
ROE-41.49%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Simulations Plus and the Institute of Medical Biology of the Polish Academy of Sciences Partnership Announces Results in Validation of ADMET Predictor® Models with Enhanced AI Drug Design

RESEARCH TRIANGLE PARK, N.C., July 29, 2025--Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that experimental results of its artificial intelligence-driven drug design (AIDD) collaboration with the Institute of Medical Biology of the Polish Academy of Sciences (IMB PAS) have been published in the America

Article Link

Conestoga Capital Advisors Trimmed Its Position in Simulations Plus (SLP)

Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The second quarter began with a historically poor start but gained momentum later as tariff fears subsided and market volatility dropped precipitously. Conestoga Micro Cap Composite appreciated 15.65% net-of-fees in the second quarter but underperformed the […]

Article Link

SLP Resources Berhad (KLSE:SLP) Will Be Looking To Turn Around Its Returns

What financial metrics can indicate to us that a company is maturing or even in decline? A business that's potentially...

Article Link

KeyBanc Downgrades Simulations Plus (SLP) Stock to Sector Weight

Simulations Plus, Inc. (NASDAQ:SLP) is one of the Best Beaten Down Stocks to Buy Now. KeyBanc downgraded the company’s stock to “Sector Weight” from “Overweight” without a price target, as reported by The Fly. The downgrade from the firm highlighted ongoing challenges in the biopharma end market environment, which the firm opines impacts Simulations Plus, Inc. (NASDAQ:SLP) more […]

Article Link

Simulations Plus Third Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simulations Plus ( NASDAQ:SLP ) Third Quarter 2025 Results Key Financial Results Revenue: US$20.4m (up 9.8% from 3Q...

Article Link